Bellevue Life Sciences Acquisition Corp. (57) | Uncategorized (14)
Recent Contracts
-
Description of Securities
(Filed With SEC on March 31, 2023)
-
Amended and Restated Administrative Support Agreement, dated February 9, 2023, by and between the Company and the Sponsor
(Filed With SEC on February 15, 2023)
-
Form of Amended and Restated Administrative Support Agreement by and between the Registrant and Bellevue Global Life Sciences Investors LLC
(Filed With SEC on January 20, 2023)
-
Amended and Restated Administrative Support Agreement, dated November 4, 2022 by and between the Registrant and Bellevue Global Life Sciences Investors LLC
(Filed With SEC on November 4, 2022)
-
Specimen Unit Certificate
(Filed With SEC on October 7, 2022)
-
Specimen Rights Certificate
(Filed With SEC on October 7, 2022)
-
Form of Letter Agreement among the Registrant and our officers, directors, Chardan Capital Markets, LLC and Bellevue Global Life Sciences Investors LLC
(Filed With SEC on October 7, 2022)
-
Amended and Restated Administrative Support Agreement, dated , 2022 by and between the Registrant and Bellevue Global Life Sciences Investors LLC
(Filed With SEC on October 7, 2022)
-
Form of Letter Agreement among the Registrant and our officers, directors, Chardan Capital Markets, LLC and Bellevue Global Life Sciences Investors LLC
(Filed With SEC on May 10, 2022)
-
Administrative Support Agreement, dated April 20, 2022 by and between the Registrant and Bellevue Global Life Sciences Investors LLC
(Filed With SEC on May 10, 2022)
-
Specimen Unit Certificate
(Filed With SEC on April 29, 2022)
-
Form of Letter Agreement among the Registrant and our officers, directors, Chardan Capital Markets, LLC and Bellevue Global Life Sciences Investors LLC
(Filed With SEC on April 29, 2022)
-
Form of Indemnity Agreement
(Filed With SEC on April 29, 2022)
-
Administrative Support Agreement, dated April 20, 2022 by and between the Registrant and Bellevue Global Life Sciences Investors LLC
(Filed With SEC on April 29, 2022)
